Brief report
Efficacy of sodium glucose cotransporter 2 inhibitors as an adjunct treatment for patients with diabetes type 2
Eficacia de los inhibidores del cotransportador sodio glucosa tipo 2 como tratamiento adyuvante en pacientes con diabetes tipo 2 tratados con insulina
Pedro Pujantea,1,
, Jessica Aresa,1, Carmen Maciáb, Raúl Rodriguez Escobedoa, Edelmiro Menéndeza, Elías Delgadoa
Autor para correspondencia
a Hospital Central de Asturias, Servicio de Endocrinología y Nutrición, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
b Hospital San Agustín, Servicio de Endocrinología y Nutrición, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avilés, Asturias, Spain
Leído
111
Vecesse ha leído el artículo
11
Total PDF
100
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 2 | 0 | 2 |
| 2025 9 | 1 | 0 | 1 |
| 2025 8 | 3 | 0 | 3 |
| 2025 7 | 4 | 0 | 4 |
| 2025 6 | 1 | 0 | 1 |
| 2025 5 | 3 | 0 | 3 |
| 2025 4 | 3 | 0 | 3 |
| 2025 3 | 1 | 0 | 1 |
| 2025 2 | 6 | 0 | 6 |
| 2025 1 | 1 | 0 | 1 |
| 2024 12 | 2 | 0 | 2 |
| 2024 10 | 2 | 0 | 2 |
| 2024 9 | 1 | 0 | 1 |
| 2024 8 | 2 | 0 | 2 |
| 2024 7 | 2 | 0 | 2 |
| 2024 6 | 1 | 0 | 1 |
| 2024 5 | 1 | 0 | 1 |
| 2024 4 | 1 | 0 | 1 |
| 2024 3 | 1 | 0 | 1 |
| 2024 2 | 3 | 0 | 3 |
| 2024 1 | 2 | 0 | 2 |
| 2023 12 | 1 | 0 | 1 |
| 2023 11 | 2 | 0 | 2 |
| 2023 10 | 5 | 0 | 5 |
| 2023 9 | 4 | 0 | 4 |
| 2023 8 | 3 | 0 | 3 |
| 2023 7 | 1 | 0 | 1 |
| 2023 6 | 1 | 0 | 1 |
| 2023 4 | 1 | 0 | 1 |
| 2023 3 | 4 | 0 | 4 |
| 2022 11 | 4 | 0 | 4 |
| 2022 10 | 1 | 0 | 1 |
| 2022 9 | 4 | 0 | 4 |
| 2022 8 | 2 | 0 | 2 |
| 2022 7 | 2 | 0 | 2 |
| 2022 6 | 2 | 0 | 2 |
| 2022 5 | 2 | 0 | 2 |
| 2022 4 | 2 | 0 | 2 |
| 2022 3 | 2 | 0 | 2 |
| 2021 11 | 1 | 0 | 1 |
| 2021 6 | 1 | 2 | 3 |
| 2020 9 | 0 | 1 | 1 |
| 2019 7 | 1 | 2 | 3 |
| 2019 6 | 8 | 2 | 10 |
| 2019 5 | 3 | 2 | 5 |
| 2018 12 | 0 | 2 | 2 |
Mostrar todo
